Arash A. Khazei (Chief Executive Officer)
Arash A. Khazei was appointed Chief Executive Officer of Envy Medical in March 2016. Prior to joining the Envy Medical team, Mr. Khazei held the position of Senior Vice President at L’Oreal, managing the financial operation and integration of NYX Cosmetics subsequent to its acquisition by L’Oreal in 2014. Mr. Khazei entered NYX as its Chief Financial Officer in 2010 and was instrumental in the explosive growth of NYX Cosmetics. During his tenure, he helped to globalize the NYX brand in over 40 countries through professional, mass and specialty retailers such as ULTA, Target, CVS, and Sephora. Prior to joining NYX, Mr. Khazei was Executive Vice President and Chief Financial Officer of United PanAm Financial Corporation (UPFC), a publicly traded consumer finance company. At UPFC he built the retail infrastructure that facilitated the company’s expansion from 90 to over 140 locations in 70 markets. Mr. Khazei began his professional career working at Arthur Andersen LLP and the Walt Disney Corporation.
Mr. Khazei is a CPA, a Canadian Chartered Accountant, and earned his BA from the University of British Columbia.
Ken Karasiuk (Founder & Chief Operating Officer)
Envy Medical Inc.’s Founder, Chairman and COO, Mr. Karasiuk, is the inventor and patent holder of the SilkPeel®, the device that performs the Dermalinfusion treatment. Mr. Karasiuk has a proven track record in both sales management and product development. After serving as an independent distributor for Luxar Laser and ESC Medical Systems, from the very first sales to becoming the prominent leader in laser sales, he then was called upon by a group of private investors to manage a start-up company in the medical device industry, General Project Firenze Italy, to co-develop and secure regulatory approval for the MD Peel dermabrasion device.
It was his familiarity with the aesthetic surgery market segment that brought Mr. Karasiuk to found emed, Inc. Since then, he has transformed emed from a distributor of medical equipment into an innovator in the aesthetic medicine space.
Mr. Karasiuk has successfully pursued several roles in the business world, including the acquisition and management of a $40 million portfolio of diversified real estate properties. He also served as the CFO of a venture capital company (Eurorient Investment Group) that made highly profitable investments in the medical industry. Mr Karasiuk attended J. H. Bruns College in Winnipeg, Manitoba, Canada.
Felipe Jimenez, Ph.D. (Chief Scientific Officer)
Dr. Jimenez is a skin care/dermatology product development executive with a Ph.D. in Biochemistry and extensive experience in developing skin care products, from concept to commercial launch, for the physician-dispensed, direct-to-consumer and mass retail markets. He possesses over 15 years of fast-track R&D leadership experience and a strong record of building robust product pipelines and intellectual property portfolios for the development of high value skin care products. In his previous role, Dr. Jimenez was Founder and President of jDerm Consulting, Inc. In this role, he provided skin care product development consulting services to corporate clients ranging from startups to Fortune 500 companies in the aesthetic medical device, direct-to-consumer and physician-dispensed sales channels. Prior to this role, he served as the Director of Scientific Affairs at Obagi Medical Products, where he directed research and product development, specializing in physician-dispensed dermatology products. In previous roles, Dr. Jimenez held senior management positions at Human Matrix Sciences, LLC and Connective Tissue Engineering, LLC. Prior accomplishments include nine publications in peer-reviewed scientific/medical journals and nine issued and pending patent applications.
Sona Tolani (Senior Vice President of Marketing)
Ms. Tolani leads all the global marketing strategy for Envy Medical. She joined Envy Medical from Dermalogica, acquired by Unilever, where she was Senior Director of Global Marketing and brings more than 15 years of experience in the beauty industry to Envy Medical. During her tenure at Dermalogica, Ms. Tolani was responsible for driving the global marketing strategy for new products and brands. Prior to joining Dermalogica, Ms. Tolani was Senior Marketing Manager of cosmetics at L’Oreal Paris, where she was instrumental in growing the eye category, including mascara, eyeliners, and eye shadows. She began her career in the beauty industry in hair care for salon brand Sebastian International, acquired by Proctor and Gamble, developing new product concepts and initiatives.
Ms. Tolani earned a BBA in Marketing from Loyola Marymount University.
Brendon Boone (Vice President of Operations)
Mr. Boone has been in charge of Operations for the company since 2006, overseeing its daily business operations, including Customer Support & Service, Warehousing & International Distribution, Regulatory Affairs & Product Quality, and all Manufacturing functions. Mr. Boone joined emed, Incorporated, Envy’s predecessor company, in December 2000, shortly after it was founded.
During his time with the Company he has served in various management and product development roles, and led the product engineering and design teams in bringing both the first SilkPeel® Dermalinfusion® devices and topical solutions from concept to commercial production in 2003. During this time, he worked with various distribution partners in establishing the international presence of the SilkPeel brand while also developing the manufacturing and other operational infrastructures of the Company. He is accredited in various areas of regulatory affairs, quality systems regulations, and good manufacturing practices.
Mr. Boone is also responsible for the commercial scale-up manufacturing of new systems and products, and remains actively involved in the research and development of the company’s many technologies. He is co-inventor on several of the company’s patents and related technology innovations.
Prior to working for Envy Medical, Mr. Boone worked for Cambridge Healthtech Institute (CHI) from 1997 to 2000, working with leading biotech companies through collaborative development vehicles such as the Human Genome Project, Structure-based Drug Discovery, and others.
Michael Healey, CPA (Controller)
Mr. Healey was appointed Controller of Envy Medical in April 2016 and is responsible for the company’s finance and accounting functions. Mr. Healey has over 20 years of accounting and finance experience in both public accounting and private enterprise. Prior to joining Envy Medical, Mr. Healey held executive managerial roles in the medical device and high tech industries, serving as Controller at Bitcentral, Inc., American Cleanstat, LLC, NeoMend, Inc., and managing Accounting functions at MicroVention Terumo, Inc.
Mr. Healey is a knowledgeable CPA, certified by the state of California in 2002. He received his Bachelor’s Degree in Economics from University of California at Los Angeles.